Shares of pharmaceutical company Pfizer, Inc. (PFE) declined after multiple attempts to merge with UK competitor AstraZeneca ultimately failed.
From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Second Quarter 2014 Commentary.
Shares of pharmaceutical company Pfizer, Inc. (PFE) declined after multiple attempts to merge with UK competitor AstraZeneca ultimately failed.
From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Second Quarter 2014 Commentary.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey